Oracle CDR (ORAC.CA) Fundamental Analysis & Valuation

TSX:ORAC

Current stock price

8.64 CAD
+0.01 (+0.12%)
Last:

This ORAC.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ORAC.CA Profitability Analysis

1.1 Basic Checks

  • In the past year ORAC was profitable.
  • In the past year ORAC had a positive cash flow from operations.
  • ORAC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ORAC had a positive operating cash flow.
ORAC.CA Yearly Net Income VS EBIT VS OCF VS FCFORAC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

1.2 Ratios

  • With a decent Return On Assets value of 6.60%, ORAC is doing good in the industry, outperforming 79.71% of the companies in the same industry.
  • The Return On Equity of ORAC (42.05%) is better than 94.20% of its industry peers.
  • ORAC's Return On Invested Capital of 8.92% is fine compared to the rest of the industry. ORAC outperforms 73.91% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ORAC is in line with the industry average of 12.70%.
Industry RankSector Rank
ROA 6.6%
ROE 42.05%
ROIC 8.92%
ROA(3y)7.05%
ROA(5y)7.55%
ROE(3y)324.52%
ROE(5y)N/A
ROIC(3y)11.78%
ROIC(5y)12.8%
ORAC.CA Yearly ROA, ROE, ROICORAC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600

1.3 Margins

  • Looking at the Profit Margin, with a value of 25.26%, ORAC belongs to the top of the industry, outperforming 92.75% of the companies in the same industry.
  • ORAC's Profit Margin has declined in the last couple of years.
  • ORAC's Operating Margin of 32.16% is amongst the best of the industry. ORAC outperforms 97.10% of its industry peers.
  • In the last couple of years the Operating Margin of ORAC has declined.
  • With a decent Gross Margin value of 67.08%, ORAC is doing good in the industry, outperforming 68.12% of the companies in the same industry.
  • ORAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 32.16%
PM (TTM) 25.26%
GM 67.08%
OM growth 3Y-5.7%
OM growth 5Y-2.96%
PM growth 3Y11.06%
PM growth 5Y-3.53%
GM growth 3Y-3.75%
GM growth 5Y-2.42%
ORAC.CA Yearly Profit, Operating, Gross MarginsORAC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ORAC.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ORAC is creating value.
  • ORAC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ORAC has less shares outstanding
  • The debt/assets ratio for ORAC has been reduced compared to a year ago.
ORAC.CA Yearly Shares OutstandingORAC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
ORAC.CA Yearly Total Debt VS Total AssetsORAC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 0.62, we must say that ORAC is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ORAC (0.62) is comparable to the rest of the industry.
  • ORAC has a Debt/Equity ratio of 3.39. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ORAC (3.39) is worse than 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.39
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACC1.49
WACC5.98%
ORAC.CA Yearly LT Debt VS Equity VS FCFORAC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • ORAC has a Current Ratio of 1.35. This is a normal value and indicates that ORAC is financially healthy and should not expect problems in meeting its short term obligations.
  • ORAC's Current ratio of 1.35 is in line compared to the rest of the industry. ORAC outperforms 59.42% of its industry peers.
  • A Quick Ratio of 1.35 indicates that ORAC should not have too much problems paying its short term obligations.
  • ORAC's Quick ratio of 1.35 is in line compared to the rest of the industry. ORAC outperforms 59.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
ORAC.CA Yearly Current Assets VS Current LiabilitesORAC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ORAC.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.14% over the past year.
  • The Earnings Per Share has been growing by 9.22% on average over the past years. This is quite good.
  • The Revenue has grown by 14.87% in the past year. This is quite good.
  • ORAC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 8.00% yearly.
EPS 1Y (TTM)21.14%
EPS 3Y7.09%
EPS 5Y9.22%
EPS Q2Q%21.77%
Revenue 1Y (TTM)14.87%
Revenue growth 3Y10.59%
Revenue growth 5Y8%
Sales Q2Q%21.66%

3.2 Future

  • ORAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.24% yearly.
  • The Revenue is expected to grow by 31.56% on average over the next years. This is a very strong growth
EPS Next Y26.48%
EPS Next 2Y16.32%
EPS Next 3Y22.67%
EPS Next 5Y28.24%
Revenue Next Year17.87%
Revenue Next 2Y24.69%
Revenue Next 3Y31.92%
Revenue Next 5Y31.56%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ORAC.CA Yearly Revenue VS EstimatesORAC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B
ORAC.CA Yearly EPS VS EstimatesORAC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

8

4. ORAC.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 0.87, which indicates a rather cheap valuation of ORAC.
  • ORAC's Price/Earnings ratio is rather cheap when compared to the industry. ORAC is cheaper than 98.55% of the companies in the same industry.
  • ORAC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.35.
  • A Price/Forward Earnings ratio of 0.77 indicates a rather cheap valuation of ORAC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ORAC indicates a rather cheap valuation: ORAC is cheaper than 97.10% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ORAC to the average of the S&P500 Index (22.23), we can say ORAC is valued rather cheaply.
Industry RankSector Rank
PE 0.87
Fwd PE 0.77
ORAC.CA Price Earnings VS Forward Price EarningsORAC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ORAC is valued cheaply inside the industry as 88.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.15
ORAC.CA Per share dataORAC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ORAC may justify a higher PE ratio.
  • A more expensive valuation may be justified as ORAC's earnings are expected to grow with 22.67% in the coming years.
PEG (NY)0.03
PEG (5Y)0.09
EPS Next 2Y16.32%
EPS Next 3Y22.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ORAC.CA Dividend Analysis

5.1 Amount

  • ORAC has a Yearly Dividend Yield of 1.13%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.47, ORAC pays a better dividend. On top of this ORAC pays more dividend than 92.75% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.82, ORAC is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

  • The dividend of ORAC is nicely growing with an annual growth rate of 12.29%!
  • ORAC does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)12.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • ORAC pays out 35.14% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of ORAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.14%
EPS Next 2Y16.32%
EPS Next 3Y22.67%
ORAC.CA Yearly Income VS Free CF VS DividendORAC.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
ORAC.CA Dividend Payout.ORAC.CA Dividend Payout, showing the Payout Ratio.ORAC.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ORAC.CA Fundamentals: All Metrics, Ratios and Statistics

Oracle CDR

TSX:ORAC (4/27/2026, 7:00:00 PM)

8.64

+0.01 (+0.12%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-10
Earnings (Next)06-09
Inst Owners44.24%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap24.85B
Revenue(TTM)64.08B
Net Income(TTM)16.19B
Analysts81.57
Price Target12.67 (46.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend2.33
Dividend Growth(5Y)12.29%
DP35.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.16%
Min EPS beat(2)3.08%
Max EPS beat(2)35.24%
EPS beat(4)3
Avg EPS beat(4)9.26%
Min EPS beat(4)-2.65%
Max EPS beat(4)35.24%
EPS beat(8)4
Avg EPS beat(8)3.86%
EPS beat(12)7
Avg EPS beat(12)2.99%
EPS beat(16)9
Avg EPS beat(16)2.52%
Revenue beat(2)0
Avg Revenue beat(2)-1.62%
Min Revenue beat(2)-2.88%
Max Revenue beat(2)-0.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-2.88%
Max Revenue beat(4)0.02%
Revenue beat(8)1
Avg Revenue beat(8)-2.14%
Revenue beat(12)1
Avg Revenue beat(12)-2.11%
Revenue beat(16)1
Avg Revenue beat(16)-1.88%
PT rev (1m)-11.73%
PT rev (3m)-15.62%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)0.14%
EPS NY rev (1m)1.44%
EPS NY rev (3m)1.36%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 0.87
Fwd PE 0.77
P/S 0.28
P/FCF N/A
P/OCF 0.77
P/B 0.47
P/tB N/A
EV/EBITDA 4.15
EPS(TTM)9.88
EY114.35%
EPS(NY)11.16
Fwd EY129.19%
FCF(TTM)-11.77
FCFYN/A
OCF(TTM)11.19
OCFY129.46%
SpS30.48
BVpS18.31
TBVpS-13.04
PEG (NY)0.03
PEG (5Y)0.09
Graham Number63.8014 (638.44%)
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 42.05%
ROCE 10.08%
ROIC 8.92%
ROICexc 11.03%
ROICexgc 18.34%
OM 32.16%
PM (TTM) 25.26%
GM 67.08%
FCFM N/A
ROA(3y)7.05%
ROA(5y)7.55%
ROE(3y)324.52%
ROE(5y)N/A
ROIC(3y)11.78%
ROIC(5y)12.8%
ROICexc(3y)12.95%
ROICexc(5y)16.53%
ROICexgc(3y)38.77%
ROICexgc(5y)55.56%
ROCE(3y)13.31%
ROCE(5y)14.46%
ROICexgc growth 3Y-23.67%
ROICexgc growth 5Y-30%
ROICexc growth 3Y-14.81%
ROICexc growth 5Y-10.94%
OM growth 3Y-5.7%
OM growth 5Y-2.96%
PM growth 3Y11.06%
PM growth 5Y-3.53%
GM growth 3Y-3.75%
GM growth 5Y-2.42%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 3.39
Debt/FCF N/A
Debt/EBITDA 4.54
Cap/Depr 592.53%
Cap/Sales 75.3%
Interest Coverage 250
Cash Conversion 81.79%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 0.62
F-Score5
WACC5.98%
ROIC/WACC1.49
Cap/Depr(3y)199.27%
Cap/Depr(5y)163.1%
Cap/Sales(3y)22.44%
Cap/Sales(5y)16.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.14%
EPS 3Y7.09%
EPS 5Y9.22%
EPS Q2Q%21.77%
EPS Next Y26.48%
EPS Next 2Y16.32%
EPS Next 3Y22.67%
EPS Next 5Y28.24%
Revenue 1Y (TTM)14.87%
Revenue growth 3Y10.59%
Revenue growth 5Y8%
Sales Q2Q%21.66%
Revenue Next Year17.87%
Revenue Next 2Y24.69%
Revenue Next 3Y31.92%
Revenue Next 5Y31.56%
EBIT growth 1Y16.33%
EBIT growth 3Y4.29%
EBIT growth 5Y4.8%
EBIT Next Year50.32%
EBIT Next 3Y40.37%
EBIT Next 5Y34.15%
FCF growth 1Y-301.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.92%
OCF growth 3Y29.72%
OCF growth 5Y9.64%

Oracle CDR / ORAC.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Oracle CDR?

ChartMill assigns a fundamental rating of 6 / 10 to ORAC.CA.


What is the valuation status of Oracle CDR (ORAC.CA) stock?

ChartMill assigns a valuation rating of 8 / 10 to Oracle CDR (ORAC.CA). This can be considered as Undervalued.


How profitable is Oracle CDR (ORAC.CA) stock?

Oracle CDR (ORAC.CA) has a profitability rating of 6 / 10.


What is the financial health of Oracle CDR (ORAC.CA) stock?

The financial health rating of Oracle CDR (ORAC.CA) is 3 / 10.


Can you provide the expected EPS growth for ORAC stock?

The Earnings per Share (EPS) of Oracle CDR (ORAC.CA) is expected to grow by 26.48% in the next year.